Skanska has, as a part of a joint venture, signed a contract with National Grid to design and construct a tunnel underneath the river Humber on the east coast of Northern England for the Humber Tunnel project. The contract value for Skanska is GBP 40M, about SEK 480M, which will be included in the order bookings for Skanska UK in the second quarter 2016. The joint venture with the Austrian construction company PORR and A.Hak from the Netherlands brings together international expertise to deliver, in an innovative, sustainable and collaborative way, a five-kilometer tunnel. The tunnel will protect the pipeline for the long term, helping National Grid to provide a vital service to millions of people. The River Humber pipeline is part of the national transmission system – connecting the import terminal at Easington, on the East Yorkshire coast, to the wider network and delivering gas to millions of customers throughout the UK. Skanska UK reported revenues of about SEK 18 billion in 2015. It has around 5,500 employees. The company is active in building and civil construction, utilities and building services, as well as facilities management and commercial development. For further information please contact: Kevin Perlmutter, Head of Media Relations, Skanska UK, tel +44 1923 423906 Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94 Direct line for media: tel: +46 (0)10-448 88 99 This and previous releases can also be found at www.skanska.com Skanska AB discloses the information provided herein pursuant to the Securities Market Act. Skanska is one of the world’s leading construction and project development companies, focused on selected home markets in the Nordic region, other European countries and North America. Supported by global trends in urbanization and demographics, and by being at the forefront in sustainability, Skanska offers competitive solutions for both simple and the most complex assignments, helping to build a sustainable future for customers and communities. The Group currently has 43,100 employees in selected home markets in Europe and North America. Skanska's sales in 2015 totaled SEK 155 billion.
Skanska builds tunnel for National Grid pipeline in
Top 10 Most Recent News Articles
Veterinary Biologics Growth Has a Valuable Catch Ahead
Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...
Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle
Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...
Continue Reading
Trip.Best Expands Global Travel Discovery Footprint
Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...
Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead
November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...
Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now
A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...
Continue Reading
Surgery Partners Deal Faces Fresh Price Scrutiny Ahead
A $23.50 cash offer can look wonderfully tidy until somebody asks how the number was built. That is where Surgery Partners shareholders find themselves after Halper Sadeh LLC said it is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners. The firm is examining whether the company’s board obtained a fair price, ran a conflict-free process,...
Continue Reading
Franklin County Trees Raise Funds and Honor Veterans
Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...
Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print
Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...
Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor
Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...
Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs
Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...
Continue ReadingTop 5 Most Recently Viewed Articles
Deere & Co's Future Amid Repair Debates and Financial Insights
Barclays Reconfirms Target for Deere & Co Barclays recently reaffirmed its Overweight rating on Deere & Co (NYSE: DE) and maintained a $400 price target, amidst an ongoing dialogue surrounding the right to repair. This discussion has re-emerged in the spotlight, temporarily impacting Deere's share price before it regained ground. The analyst noted that this issue has been...
Continue Reading
Inventor Offers Hospital Sign to Prevent Infections
A Fresh Take on Infection Control Some days you stumble across an idea that just clicks—like the latest gadget for hospitals. Forget complex systems or high-tech cameras; this is about a simple sign that screams 'stop!' before you walk into trouble. It’s designed to safeguard hospital staff by alerting them to take precautions before entering rooms with infectious...
Continue Reading
JPMorgan Adjusts NOV Stock Outlook Amidst Market Challenges
JPMorgan Adjusts NOV Stock Outlook Recently, JPMorgan made changes to its financial outlook for NOV Inc. (NYSE: NOV), a key player in the energy equipment and services sector. The investment firm lowered its price target from $23 to $22 but maintained an Overweight rating on the stock. This adjustment was driven by expectations of a slowdown in North American operations...
Continue Reading
Madrigal Pharmaceuticals Expands Workforce with Incentive Awards
Madrigal Pharmaceuticals Strengthens Workforce with New Grants Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a leading biopharmaceutical company dedicated to innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH), has recently taken a significant step to bolster its team. The company announced granting equity inducement awards to 76 new...
Continue Reading
Pomerantz Investigates Investor Claims Against Abacus Global Management
Pomerantz Law Firm's Investigation into Abacus Global Management In recent news, the Pomerantz Law Firm has embarked on an investigation regarding Abacus Global Management, Inc. (NASDAQ: ABL). This investigation revolves around potential securities fraud and other unlawful business practices committed by the company and some of its executive members. For investors...
Continue Reading